Recursion Pharmaceuticals, Inc. (RXRX) has a market capitalization of $1.58B and trades at $3.54. The 52-week range is 2.8-7.18.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.5, Earnings Per Share (EPS) of $-1.44, annual revenue of $74.68M.
The stock has a beta of 1.01, operates in the Healthcare sector.
